‘‘We see growing interest of healthcare testing labs, Pharmaceutical QC and R&D labs in implementing next-gen lab automation solutions''
Bio Spectrum|July 2021
US-based Abbott Informatics, formerly known as STARLIMS, is one of the companies with a long and established presence in the space of lab automation. Taking pride in offering the world class technological solutions, the company has recently announced the launch of STARLIMS Quality Manufacturing Solution QM12.2 which is built on the latest STARLIMS Technology V12 platform, along with STARLIMS SDMS (Scientific Data Management System) V12.2. To find out more about the company’s automated offerings in India, BioSpectrum spoke to Pradeep Nagisetty, Regional Sales Manager - India & Sub Continent, Abbott Informatics - STARLIMS, Hyderabad.
Dr Manbeena Chawla

Pradeep Nagisetty, Regional Sales Manager India & Sub Continent, Abbott Informatics STARLIMS, Hyderabad

Can you tell us about the major product releases of STARLIMS since 2020?

It’s the result of regular collaborations with our fantastic customer base, allowing us to hear from those that will benefit the most from this. We then take into consideration the overall market trends to enable our R&D and product teams to incorporated this feedback into new product releases, technology upgrades, critical bug fixes, data integrity improvement, performance improvements and cyber security enhancements. Our commitment to continual releases and improvements provides our customers with a LIMS solution that will remain relevant.

Since 2020, we have already released two minor versions of STARLIMS QM solution for the pharmaceutical and other manufacturing industries. We offer an Automated Validation Framework and Testing Kit that reduce the time, cost, resources and complexity over the manual testing methods. With STARLIMS QM V12.2 released in April 2021, we have brought new integration capabilities – SAP4/HANA Integration, interface with Biovia Draw and Biovia Direct for chemical structures, Thermo Chromeleon 7.3 CDS interface upgrade, Waters Empower 3 FR5 CDS interface upgrade.

This year we have the new SDMS product – Scientific Data Management System. A standalone SDMS software that helps with automatic lab equipment integration, raw data and process data capturing, data storage in folders, search and reporting, long term data storage and archival, assuring highest data integrity in the regulatory labs.

For the first time, we launched LES – Lab Execution System product. With our LES, our customers can ensure Standard Operating Procedures (SOPs) are being followed and tasks are being developed in a compliant and controlled manner for regulated labs. This is a fully touch enabled interface system that works seamlessly on smart devices and is fully mobile enabled in the labs.

We have a very strong roadmap in place and will bring more advanced products and tools to the market continually.

What are the major challenges for companies in life science sector in India?

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”

Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;

4 mins read
Bio Spectrum
September 2021

Premas Biotech to commercialise VLP vaccine tech against Delta variant

Gurugram-based Premas Biotech has signed a licensing deal with Oravax Medical for the development and commercialisation of its virus-like-particle COVID-19 vaccine technology.

1 min read
Bio Spectrum
September 2021

SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future

The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!

4 mins read
Bio Spectrum
September 2021

Merck launches Pergoveris Pen for fertility treatment in India

Merck Specialties, the healthcare business of Merck in India, has launched Pergoveris Pen for advanced infertility treatment in India.

1 min read
Bio Spectrum
September 2021

How tech innovations impact cardiac care

Cardiac care has seen a transformation over the years with technology playing an important role. Armed with Artificial intelligence (AI) and machine learning (ML), cardiac care providers, with the right technology, have received the right impetus to revolutionise treatment mechanisms. Let us delve into the new technologies which the industry is offering to mankind and decipher the way forward.

6 mins read
Bio Spectrum
September 2021

GUNG-HO PHARMA R&D INVESTMENTS SURPASS $3B

While the pharmaceutical industry helped combat COVID-19, from R&D actions on potential treatment strategies to balancing the medicines supply chain in the time of crisis, it struggled to maintain the natural market flow. As a result, many pharma companies had to abort some of their ongoing R&D investment plans. However for FY20-21, the average R&D expenses constituted 7.2 per cent of the total revenues of the pharma companies, with Lupin, Alembic Pharma and Dr. Reddy’s spending more than others. The cumulative R&D expenditure of the leading 10 pharma companies has been around Rs 10,627 crore ($1.43 billion) in the previous fiscal. This figure eventually reaches an approximate amount of Rs 22,500 crore ($3.03 billion) after considering the cumulative expenditure by other small and medium players of the India pharma industry.

10+ mins read
Bio Spectrum
September 2021

Glenmark ties up with SaNOtize to commercialise COVID-19 nasal spray

Mumbai-based Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research & Development Corporation

1 min read
Bio Spectrum
September 2021

CEPI prioritises Rift Valley fever vax

Sep 01, Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has signed an implementing partner agreement with Integrum Scientific (US) as part of its ongoing efforts to combat Rift Valley fever (RVF)—one of its priority diseases with epidemic potential.

1 min read
Bio Spectrum
September 2021

3D printing moulds healthcare innovations

Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.

7 mins read
Bio Spectrum
September 2021

Mynvax Offers ‘Warm Vaccine' For COVID-19

Biotech startup Mynvax, incubated at the Indian Institute of Science (IISc) in Bengaluru, has developed heat-tolerant COVID-19 vaccine formulations.

1 min read
Bio Spectrum
September 2021
RELATED STORIES

Simple STEP STOOL

A fresh approach to a Shaker tradition

7 mins read
Woodcraft Magazine
October - November 2021

HICKORY

As tough as they come

4 mins read
Woodcraft Magazine
October - November 2021

Murphy BED

Create a convertible bedroom with cool cabinetry, the right hardware kit, and clear instructions.

10 mins read
Woodcraft Magazine
October - November 2021

FUN with FRIDGE MAGNETS

Have a micro-blast turning precious scrap into useful hangers-on

5 mins read
Woodcraft Magazine
October - November 2021

COVE CUTTING

Dramatic curves from your table saw

7 mins read
Woodcraft Magazine
October - November 2021

Arts & Crafts WALL CLOCK

My mission to create a Craftsman clock on the table saw

6 mins read
Woodcraft Magazine
October - November 2021

IRELAND INVESTIGATES TIKTOK OVER CHILD, CHINA DATA CONCERNS

TikTok is facing two EU data privacy investigations, one into its handling of children’s personal data and another over its data transfers to China.

1 min read
Techlife News
Techlife News #516

TESLA BUILDS 1ST STORE ON TRIBAL LAND, DODGES STATE CAR LAWS

Carmaker Tesla has opened a store and repair shop on Native American land for the first time, marking a new approach to its years-long fight to sell cars directly to consumers and cut car dealerships out of the process.

3 mins read
Techlife News
Techlife News #516

NUCLEAR SUBMARINE DEAL WILL RESHAPE INDO-PACIFIC RELATIONS

The U.S., Britain and Australia have announced they’re forming a new security alliance that will help equip Australia with nuclear-powered submarines. The alliance will see a reshaping of relations in the Indo-Pacific region and beyond. Here’s what it might mean for various players:

3 mins read
Techlife News
Techlife News #516

INTERNET FUNDING RULE COULD FAVOR RURAL AREAS OVER CITIES

Cities and urban counties across the U.S. are raising concerns that a recent rule from President Joe Biden’s administration could preclude them from tapping into $350 billion of coronavirus relief aid to expand high-speed internet connections.

5 mins read
Techlife News
Techlife News #516